---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-071353"
form_type: "8-K"
ticker: "BRKR"
cik: "0001109354"
company_name: "BRUKER CORP"
filed_at: "2025-05-14T23:59:59+00:00"
generated_at: "2026-05-21T07:51:55.421530+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bruker and 10x Genomics settle all global patent litigation with cross-license agreements

## Summary
- Settlement resolves all patent disputes between Bruker and 10x Genomics, including multiple litigations in US, Germany, and European Unified Patent Court.
- All ongoing lawsuits and administrative proceedings will be withdrawn under global patent cross license agreements.
- Bruker's CosMx and GeoMx spatial biology platforms no longer face litigation risk; company can focus on research.
- No financial terms of settlement disclosed; parties entered into cross-license agreements.

## SEC filing metadata
- accession: 0000950170-25-071353
- form_type: 8-K
- ticker: BRKR
- cik: 0001109354
- company_name: BRUKER CORP
- filed_at: 2025-05-14T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1109354/000095017025071353/0000950170-25-071353-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1109354/000095017025071353/brkr-20250514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-071353
- JSON: https://secwatch.observer/filing/0000950170-25-071353.json
- Plain text: https://secwatch.observer/filing/0000950170-25-071353.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.